Jin H Cai, DO - Medicare Psychiatry & Neurology in Oregon City, OR

Jin H Cai, DO is a medicare enrolled "Psychiatry & Neurology - Child & Adolescent Psychiatry" physician in Oregon City, Oregon. His current practice location is 1511 Division St Ste 101, Oregon City, Oregon. You can reach out to his office (for appointments etc.) via phone at (971) 345-5060.

Jin H Cai is licensed to practice in Oregon (license number DO204118) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1174973358.

Contact Information

Jin H Cai, DO
1511 Division St Ste 101,
Oregon City, OR 97045-1589
(971) 345-5060
Not Available



Physician's Profile

Full NameJin H Cai
GenderMale
SpecialityPsychiatry & Neurology - Child & Adolescent Psychiatry
Location1511 Division St Ste 101, Oregon City, Oregon
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1174973358
  • Provider Enumeration Date: 06/17/2016
  • Last Update Date: 02/28/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0446543359
  • Enrollment ID: I20210802003162

Medical Identifiers

Medical identifiers for Jin H Cai such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174973358NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0804XPsychiatry & Neurology - Child & Adolescent Psychiatry DO204118 (Oregon)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jin H Cai allows following entities to bill medicare on his behalf.
Entity NameProvidence Health & Services Oregon
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023488343
PECOS PAC ID: 0648183608
Enrollment ID: O20031106000652

News Archive

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

Flu virus can be passed on before appearance of symptoms

Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms. If the finding applies to humans, it means that people pass on flu to others before they know they're infected, making it very difficult to contain epidemics.

Link between poverty and obesity is only about 30 years old, study shows

It's a fact: poverty and obesity are intimately connected. But this relationship is only about 30 years old, according to a new study coauthored by UT researchers and published in Palgrave Communications, an open-access, online journal.

FDA approves distribution of ZOLL E Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement. The product is immediately available for shipment.

Read more Medical News

› Verified 6 days ago

Entity NameProvidence Health & Services - Oregon
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912282369
PECOS PAC ID: 5294901922
Enrollment ID: O20120319000430

News Archive

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

Flu virus can be passed on before appearance of symptoms

Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms. If the finding applies to humans, it means that people pass on flu to others before they know they're infected, making it very difficult to contain epidemics.

Link between poverty and obesity is only about 30 years old, study shows

It's a fact: poverty and obesity are intimately connected. But this relationship is only about 30 years old, according to a new study coauthored by UT researchers and published in Palgrave Communications, an open-access, online journal.

FDA approves distribution of ZOLL E Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement. The product is immediately available for shipment.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jin H Cai is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jin H Cai, DO
Po Box 3158,
Portland, OR 97208-3158

Ph: (503) 215-6494
Jin H Cai, DO
1511 Division St Ste 101,
Oregon City, OR 97045-1589

Ph: (971) 345-5060

News Archive

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

Flu virus can be passed on before appearance of symptoms

Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms. If the finding applies to humans, it means that people pass on flu to others before they know they're infected, making it very difficult to contain epidemics.

Link between poverty and obesity is only about 30 years old, study shows

It's a fact: poverty and obesity are intimately connected. But this relationship is only about 30 years old, according to a new study coauthored by UT researchers and published in Palgrave Communications, an open-access, online journal.

FDA approves distribution of ZOLL E Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement. The product is immediately available for shipment.

Read more News

› Verified 6 days ago


Psychiatry & Neurology Doctors in Oregon City, OR

Kevin J Jamison, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1510 Division St Ste 180, Oregon City, OR 97045
Phone: 503-742-6900    
Kim A Wennhold, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 998 Library Ct, Oregon City, OR 97045
Phone: 503-655-8401    Fax: 503-655-8429
Maria V Prokhorova, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 998 Library Ct, Oregon City, OR 97045
Phone: 503-655-8401    Fax: 503-655-8429
Zachary P Muscato, D.O.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1511 Division St Ste 101, Oregon City, OR 97045
Phone: 971-345-5060    
Dr. Eileen Kerin Kilmartin Mccarty, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1500 Division St, 1st Floor, Oregon City, OR 97045
Phone: 503-722-3705    
Donald Dewitt Saint Just, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 998 Library Ct, Oregon City, OR 97045
Phone: 503-655-8401    Fax: 503-655-8429

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.